NEW YORK (GenomeWeb News) – Queens University in Belfast said today it will lead a €6 million ($8.3 million) international project that seeks to investigate genes that make bowel cancer so deadly and hard to treat.

Funded by the European Commission's Seventh Framework Programme, the MErCuRIC project will focus on genes that may be involved in a particularly aggressive type of colorectal cancer that affects around 50 percent of CRC patients, and which has a five-year survival rate of less than five percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.